These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 11304502)

  • 1. Diabetes, hypertension, and cardiovascular disease: an update.
    Sowers JR; Epstein M; Frohlich ED
    Hypertension; 2001 Apr; 37(4):1053-9. PubMed ID: 11304502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    Sowers JR; Frohlich ED
    Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for special populations: diabetes mellitus and the metabolic syndrome.
    Sowers JR
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):41S-45S. PubMed ID: 14625160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ACE inhibitors in treating hypertensive diabetic patients.
    Kirpichnikov D; Sowers JR
    Curr Diab Rep; 2002 Jun; 2(3):251-7. PubMed ID: 12643181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the biology of diabetic vascular disease: what's new?
    Sowers JR; Stump CS
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):2S-6S; quiz A2-4. PubMed ID: 15539107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors in diabetic patients with hypertension.
    Winer N; Sowers JR
    Curr Diab Rep; 2002 Jun; 2(3):263-6. PubMed ID: 12643183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes.
    Naidoo DP
    Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic vascular disease and hypertension.
    Hamaty M; Lamberti M; Sowers JR
    Curr Opin Cardiol; 1998 Sep; 13(5):298-303. PubMed ID: 9823785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment guidelines for a patient with diabetes and hypertension.
    Mogensen CE
    J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes and hypertension].
    Sayk F; Iwen KA; Lehnert H
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2296-301. PubMed ID: 19876807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and diabetes.
    Jandeleit-Dahm K; Cooper ME
    Curr Opin Nephrol Hypertens; 2002 Mar; 11(2):221-8. PubMed ID: 11856916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension in patients with type 2 diabetes mellitus: Targets and management.
    Pavlou DI; Paschou SA; Anagnostis P; Spartalis M; Spartalis E; Vryonidou A; Tentolouris N; Siasos G
    Maturitas; 2018 Jun; 112():71-77. PubMed ID: 29704920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and diabetes.
    Sowers JR; Levy J; Zemel MB
    Med Clin North Am; 1988 Nov; 72(6):1399-414. PubMed ID: 3054360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.
    Kalantarinia K; Siragy HM
    Curr Diab Rep; 2002 Oct; 2(5):423-30. PubMed ID: 12643168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade.
    Menne J; Chatzikyrkou C; Haller H
    J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of antihypertensive therapy in reducing vascular complications of type 2 diabetes. Findings from the DIabetic REtinopathy Candesartan Trials-Protect 2 study.
    Tillin T; Orchard T; Malm A; Fuller J; Chaturvedi N
    J Hypertens; 2011 Jul; 29(7):1457-62. PubMed ID: 21602709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.